drugset / Trial / NCT00598910

Effect of Omacor on Triglycerides in HIV Infected Subjects

NCT00598910

Phase 4 Terminated 51 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Omacor is likely to decrease lipid parameters in HIV infected subjects. In these subjects the lipid are decrease due to HAART treatment

Timeline

Start
2007-08
Primary completion
2008-09
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 4 g

Indications